IPL for poikiloderma of Civatte on the neck and upper chest
The mottled pattern of poikiloderma can include both color and small vessels. Compare the exact IPL module, the feature being measured and which body area the evidence covers.
Intense pulsed light is a treatment option to discuss for confirmed poikiloderma of Civatte. FDA clearance K250809 lists the condition under the Stellar M22 IPL module. A neck and upper chest clinical series reported changes in pigment and visible vessels, but it did not compare IPL with an untreated group or another procedure. A clinic should identify the pattern, name the module and explain which part of the appearance it proposes to measure.12
Why this pattern is different from separate sun spots
Poikiloderma of Civatte can show a network of reddish and brown changes rather than a row of individual brown spots. It is the combination across a field of skin that matters in the published IPL series. If your priority is the red component, a photo that mainly shows a difference in brown contrast is not a complete answer. Conversely, a vessel-focused result does not tell you how much of the brown pattern changed.12
A separate raised, changing or uncertain spot deserves its own evaluation. If a practice describes everything in the treatment field as sun damage without identifying an unusual mark, ask which findings need medical review before a cosmetic procedure. The IPL sun spot guide covers that separate question in more depth.3
Read the record at the module level
The Stellar M22 summary lists multiple modules on one platform. The poikiloderma indication is under its IPL module. The device name alone does not establish that a quoted treatment uses that module. Another platform may have a separate clearance record; the useful comparison is the exact model and configuration the practice proposes, not whether both brochures use the letters IPL.1
The clearance record and the clinical series answer different questions. Weiss and colleagues’ public abstract describes 135 selected patients treated on the neck or upper chest. It reports improvement in pigment and vessels and also records pigment changes as adverse effects. Random selection of patients is different from random assignment to treatments. The abstract does not establish how many people returned at each follow-up, and it offers no untreated group against which to assess the reported change.2
| Write down | What it helps you verify |
|---|---|
| Treatment area | Whether the proposed field is on the neck, upper chest or both. |
| Red and brown tones | Whether the planned outcome measures both or prioritizes one. |
| Device and module | Whether the cited clearance describes the actual proposed equipment. |
| Photo follow-up | Whether the same field and both color components will be reviewed under comparable conditions. |
Ask which result would be meaningful on both sites
Someone with a red neck pattern and a browner chest pattern can ask the provider to describe the goals separately. If the evidence combines sites or uses a single appearance rating, ask whether it reports a separate neck or chest outcome and whether the proposed treatment area resembles the study. The same is true of photos: a side-by-side comparison should identify the same field and distinguish a reduction in the pattern from a new pigment change. The case series makes the treatment worth discussing, but it offers no comparison of which platform or module would perform best on one site.12
Take a specific question to the provider
When comparing IPL photofacial services, ask whether the practice evaluates this neck or chest pattern. A facial listing alone tells you little about its experience with those sites. “Which component are we treating, with which module, and how will we document the same field afterward?” is a better comparison question than “Does this machine treat sun damage?”12
Sources
- U.S. Food and Drug Administration. 510(k) Summary K250809, Stellar M22. Names poikiloderma of Civatte in the Stellar M22 IPL module indications and lists the platform modules separately. Accessed .
- Dermatologic Surgery / original study. Treatment of poikiloderma of Civatte with an intense pulsed light source. Public abstract describing 135 selected patients treated on the neck or upper chest; no randomized treatment comparator. Accessed .
- American Academy of Dermatology. What can get rid of age spots?. Supports professional identification of uncertain pigmented spots before cosmetic treatment. Accessed .